Treatment of highly pathogenic filovirus infections using advanced antisense technology
Page 1 of 1
Treatment of highly pathogenic filovirus infections using advanced antisense technology
Jon Moulton Fri Apr 06, 2012 10:31 am
Warren T, Warfield K, Wells J, Swenson D, Lovejoy C, Iversen P, Bavari S. Treatment of highly pathogenic filovirus infections using advanced antisense technology. Retrovirology. 2010; 7(Suppl 1): P4. Published online 2010 May 11. doi: 10.1186/1742-4690-7-S1-P4
Last edited by Jon Moulton on Fri Apr 06, 2012 10:45 am; edited 1 time in total (Reason for editing : Author list to PubMed format)
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Advanced antisense therapies for postexposure protection against lethal filovirus infections
» Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
» To Discover, Develop and Deliver a Right Drug: A Showcase for Antisense Technology
» Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
» Glycogen reduction in myotubes of late-onset Pompe disease patients using antisense technology
» Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
» To Discover, Develop and Deliver a Right Drug: A Showcase for Antisense Technology
» Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
» Glycogen reduction in myotubes of late-onset Pompe disease patients using antisense technology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|